Detecting ESR1 Mutations in ctDNA with an 18-plex digital PCR: From Technology to Laboratory Validation

Thu, Nov 19th 2026, 4:00 PM

Detecting ESR1 Mutations in ctDNA with an 18-plex digital PCR: From Technology to Laboratory Validation

Thu, Nov 19th 2026, 4:00 PM


Activating mutations in the ligand-binding domain of ESR1 are a major mechanism of acquired resistance to endocrine therapy in ER-positive, HER2-negative advanced breast cancer, emerging in up to 40% of patients.

Their detection is becoming increasingly relevant in clinical research and molecular oncology workflows. Oral selective estrogen receptor degraders (SERDs) have received European marketing authorization for ESR1-mutated disease, including elacestrant after progression on endocrine therapy plus a CDK4/6 inhibitor and camizestrant as an early switch strategy upon emergence of an ESR1 mutation during first-line therapy, before clinical progression.

Although these treatments are not yet reimbursed in Belgium, this shift increases the need for sensitive, rapid, and repeatable ESR1 mutation testing approaches so that laboratories can prepare for potential future access.

Liquid biopsy, based on circulating tumor DNA (ctDNA) from a blood draw, can support minimally invasive and serial monitoring of ESR1 mutations in research and molecular oncology workflows. Multiplex Droplet DigitalTM PCR (ddPCRTM ) is well suited for detecting low-frequency variants across several hotspots in a single reaction, depending on assay design, sample quality, and validation parameters.

The seminar will open with an introduction to Bio-Rad's newly launched CrystalTag technology by Dr. Laras Pitayu, senior field application scientist. She will explain how ddPLEX CrystalTag technology works with Droplet Digital PCR technology to use color combinations to detect multiple targets in a single digital PCR reaction, and why this approach may support screening for multiple mutations in limited ctDNA samples. Dr. Matthieu Terwagne will then present how the Institut de Pathologie et de Génétique (IPG, Gosselies, Belgium) is validating an 18-plex ESR1 CrystalTag assay in plasma samples from breast cancer patients. The validation is being performed in accordance with ISO 15189:2022 requirements and covers accuracy, analytical sensitivity and specificity, limits of blank and detection, and precision near the limit of detection. He will share the data generated to date and discuss considerations for integrating this assay into a molecular oncology workflow.

Key Learning Objectives:

  • Understand the principles behind ddPLEX CrystalTag Technology and how it expands multiplexing capabilities on the QX700TM ddPCR platform.
  • Explore how Bio-Rad’s ddPCR solutions may support flexible, high-resolution target detection in oncology research workflows.
  • Review practical data and workflow considerations from use of an 18-plex ESR1 CrystalTag assay on the Nio system.
  • Consider how high-plex digital PCR approaches may support deeper molecular characterization while helping simplify complex assay workflows.


Speaker’s description

Laras Pitayu, PharmD, PhD
Interim Product Manager, Senior Field Application Scientist
Stilla Technologies, a Bio-Rad Laboratories Company

Matthieu Terwagne, PhD
Expert Scientifique – Responsable de service adjoint BM Onco-hématologie
Institut de Pathologie et de Génétique ASBL


The content presented in these sessions is intended for research use only and is not intended for use in diagnostic procedures. The views and opinions expressed in the recordings are those of the individual presenters and do not necessarily reflect the official policy, position, or claims of Bio-Rad Laboratories. 

Any clinical applications, test validations, or performance claims discussed are the sole responsibility of the presenting institution or speaker and do not reflect the views or endorsements of Bio-Rad Laboratories.

Any reference to clinical use, patient testing, or performance claims reflects the practices and experience of the individual institutions or researchers and should not be interpreted as endorsement by Bio-Rad.

 

For Research Use Only. Not for use in diagnostic procedures.

Become a member and enjoy exclusive benefits

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!